Patent Law Weblog
recent posts
- USPTO and DOJ Statement of Interest in Collision Communications: Another Thumb on the Scale in Favor of NPE Patent Plaintiffs
- Oasis Tooling, Inc. v. Siemens Industry Software Inc. (Fed. Cir. 2026)
- Why AI Will Not Take Over the World
- BioNTech Sues Moderna over mRNA Vaccine Technology
- CNIPA Issues Letter on Identity of Foreign Inventors
about
Month: March 2014
-
West LegalEdcenter will be offering a live webcast entitled "Understanding the New USPTO Final and Proposed Rules on PLT and the Hague Agreement" on March 13, 2014 from 12:00 to 1:00 pm (EDT). Miku H. Mehta and Michael C. Jones of Procopio, Cory, Hargreaves & Savitch LLP will discuss the changes and the law and…
-
D Young & Co will be offering its next European biotech patent law update on April 23, 2014. The 45-minute webinar will be offered at three times: 4:00 am, 7:00 am, and 12:00 pm (ET). D Young & Co European Patent Attorneys Robert Dempster and Simon O'Brien will provide an essential update and live Q&A…
-
McDonnell Boehnen Hulbert & Berghoff LLP will be offering a live webinar entitled "Big Data Litigation in an Era of Big Data Privacy Concerns: Recent Developments in International Data Privacy Law and Their Impact on U.S. Litigation" on March 25, 2014 from 10:00 am to 11:15 am (CT). MBHB attorney S. Richard Carden will review…
-
By Kevin E. Noonan — The San Diego Intellectual Property Law Association (SDIPLA) is one of two groups that have filed an amicus curiae brief urging reversal of the District Court's summary judgment decision in Ariosa Inc v. Sequenom, Inc. (The brief from the other amicus, the Biotechnology Industry Organization, BIO, will be the subject of…
-
By Andrew Williams — \ Last Thursday, Sen. McCaskill, along with Sen. Rockefeller, introduced the "Transparency in Assertion of Patents Act" (S. 2049). Of course, several other bills are currently pending in the Senate that have been introduced by such politicians as Sen. Leahy (S. 1720), Sen. Hatch (S. 1612), Sen. Cornyn (S. 1013), and…
-
By Donald Zuhn — Earlier today, in a memorandum issued to the Patent Examining Corps by Deputy Commissioner for Patent Examination Policy Andrew Hirshfeld, the U.S. Patent and Trademark Office implemented a new procedure for determining the subject matter eligibility of claims under 35 U.S.C. § 101 in view of the Supreme Court's decisions in…
-
By Michael Borella — In 2011, Cyberfone sued CNN and 80 other defendants in the U.S. District Court for the District of Delaware for infringement of U.S. Patent No. 8,019,060. On the defendants' motion for summary judgment, the District Court held the claims of the '060 patent invalid under 35 U.S.C. § 101 as being…
-
By Josh Bosman — The U.S. Patent and Trademark Office recently issued U.S. Patent No. 8,642,270, which is entitled "Prognostic biomarkers to predict overall survival and metastatic disease in patients with triple negative breast cancer." The '270 patent, which is assigned to the VM Institute of Research (Montreal, Canada), contains claims to a method of…
-
By Sherri Oslick — About Court Report: Each week we will report briefly on recently filed biotech and pharma cases. Takeda Pharmaceuticals USA Inc. v. Watson Laboratories Inc. et al.1:14-cv-00268; filed February 27, 2014 in the District Court of Delaware • Plaintiff: Takeda Pharmaceuticals USA Inc.• Defendants: Watson Laboratories Inc.; Actavis Inc. Infringement of…
-
March 5, 2014 – Ninth Annual Federal Judicial Panel (Intellectual Property Law Association of Chicago) – 5:30 to 7:30 pm (CT) March 5-7, 2014 – Advanced Patent Law Seminars (Chisum Patent Academy) – Cincinnati, OH March 6, 2014 – "Doctrine of Equivalents: Latest on Patent Prosecution and Litigation" (Intellectual Property Owners Association) – 2:00 to…
Patent Docs 